Adenylyl cyclase 1 mitigates doxorubicin-induced cardiotoxicity by reducing oxidative stress and myocardial damage
Doxorubicin (DOX), a commonly used ant-cancer drug, has its clinical application severely restricted due to its serious cardiotoxic side-effects. Adenylyl cyclase 1 (ADCY1) is recognized for its pivotal role in cardiac pathophysiology. Nonetheless, the involvement of ADCY1 in DOX-induced cardiotoxic...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
EDP Sciences
2025-01-01
|
| Series: | BIO Web of Conferences |
| Online Access: | https://www.bio-conferences.org/articles/bioconf/pdf/2025/25/bioconf_icbb2025_01014.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|